Valuation: Baxter International Inc.

Market Cap 13.07B 11.62B 10.77B 9.8B 18.49B 1,240B 18.78B 129B 50.75B 647B 49.05B 48.01B 2,063B P/E 2026 *
32.4x
P/E 2027 * 21.1x
Enterprise Value 19.97B 17.75B 16.45B 14.97B 28.24B 1,895B 28.7B 198B 77.53B 989B 74.93B 73.34B 3,152B EV / Sales 2026 *
1.72x
EV / Sales 2027 * 1.63x
Free-Float
75.39%
Yield 2026 *
0.16%
Yield 2027 * 0.16%
1 day-1.86%
1 week+3.82%
Current month+5.33%
1 month+9.82%
3 months+11.81%
6 months+35.11%
Current year+32.29%
1 week 24.34
Extreme 24.34
25.98
1 month 22.56
Extreme 22.56
25.98
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Chief Tech/Sci/R&D Officer 57 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 Other

EVP and CFO

0 0% -
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
Change 5-day change 1-year change 3-year change Capi.($)
-1.86%+3.82%+9.48%-20.60% 13.07B
+0.20%+5.31%-18.40%+13.84% 181B
-0.73%+7.09%-1.08%+30.13% 116B
+0.49%+6.25%-21.30%+9.62% 113B
+3.83%+5.50%-50.59%-6.11% 79.83B
-0.14%+5.27%+5.00%+81.87% 65.06B
+2.79%+2.37%+15.85%+65.97% 54.35B
-1.04%+4.35%+1.40%-26.05% 52.23B
+2.41%+8.18%-11.81%+28.50% 44.15B
-1.90%+2.29%+29.19%+6.90% 32.47B
Average +0.41%+5.14%-4.23%+18.41% 75.17B
Weighted average by Cap. +0.56%+5.56%-10.78%+20.45%

Financials

2026 *2027 *
Net sales 11.62B 10.33B 9.57B 8.71B 16.43B 1,103B 16.7B 115B 45.11B 575B 43.6B 42.67B 1,834B 11.87B 10.55B 9.78B 8.89B 16.78B 1,126B 17.05B 118B 46.07B 588B 44.53B 43.58B 1,873B
Net income 372M 331M 306M 279M 526M 35.31B 535M 3.68B 1.44B 18.42B 1.4B 1.37B 58.73B 687M 611M 566M 515M 972M 65.25B 988M 6.81B 2.67B 34.05B 2.58B 2.53B 109B
Net Debt 6.9B 6.13B 5.68B 5.17B 9.76B 655B 9.91B 68.3B 26.78B 342B 25.88B 25.33B 1,089B 6.32B 5.62B 5.2B 4.74B 8.94B 600B 9.08B 62.56B 24.53B 313B 23.71B 23.2B 997B
Projected Income Statement - Annual - Baxter International Inc.
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-10-16 US$25.28 -1.86% 4,406,949
26-10-15 US$25.76 +3.87% 4,508,145
26-10-14 US$24.80 -0.36% 5,209,623
26-10-13 US$24.89 +0.44% 3,249,507
26-10-12 US$24.78 +1.77% 5,234,356
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Baxter International Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
25.28USD
Average target price
27.92USD
Spread / Average Target
+10.43%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Baxter International Inc.